Overview
- 185 inspections across 133 sites are on record.
- 338 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-10-24.
At a glance
Inspections
185
Sites
133
Observations
338
Career since
Sep 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Neelakantan Anand, MD | 24 Oct 2019 | Medical Devices & Rad Health | View 483 → |
| SEAGEN INC. | 4 Oct 2019 | Human Drugs | |
| Josias S. Badenhorst, M.D. | 6 Sep 2019 | Human Drugs | |
| Andre Lacroix, MD | 30 Aug 2019 | Human Drugs | |
| Michael C. Heinrich, M.D. | 16 Aug 2019 | Human Drugs | View 483 → |
Sites inspected
Neelakantan Anand, MDLos Angeles, United States1 insp.
SEAGEN INC.Bothell, United States1 insp.
Josias S. Badenhorst, M.D.Red Deer, Canada1 insp.
Andre Lacroix, MDMontreal, Canada1 insp.
Michael C. Heinrich, M.D.Portland, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Dianna D Wardlow-Dotter5 shared
Alexander M Kay5 shared
Dirk L Lincoln5 shared
Christopher R Czajka4 shared
Jessica B Clark3 shared
Lesley A Swanson3 shared
John W Banks2 shared
Kathryn A Krentz2 shared
Jinkee M Vila Binayug2 shared
Marilyn S Babu1 shared
Full investigator report
Get the verbatim findings behind Mark W Babbitt's 338 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site